These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 32976199)

  • 1. Urinary Cellular Profile as a Biomarker for Lupus Nephritis.
    Abdelati AA; Eshak NY; Donia HM; El-Girby AH
    J Clin Rheumatol; 2021 Dec; 27(8):e469-e476. PubMed ID: 32976199
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The cellular signature of urinary immune cells in Lupus nephritis: new insights into potential biomarkers.
    Kopetschke K; Klocke J; Grießbach AS; Humrich JY; Biesen R; Dragun D; Burmester GR; Enghard P; Riemekasten G
    Arthritis Res Ther; 2015 Apr; 17(1):94. PubMed ID: 25890061
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deep Phenotyping of Urinary Leukocytes by Mass Cytometry Reveals a Leukocyte Signature for Early and Non-Invasive Prediction of Response to Treatment in Active Lupus Nephritis.
    Bertolo M; Baumgart S; Durek P; Peddinghaus A; Mei H; Rose T; Enghard P; Grützkau A
    Front Immunol; 2020; 11():256. PubMed ID: 32265898
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinico-serological associations of urinary activated leukocyte cell adhesion molecule in systemic lupus erythematosus and lupus nephritis.
    Amer AS; Abdel Moneam SM; Hashaad NI; Yousef EM; Abd El-Hassib DM
    Clin Rheumatol; 2024 Mar; 43(3):1015-1021. PubMed ID: 38294724
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mapping urinary chemokines in human lupus nephritis: Potentially redundant pathways recruit CD4
    Klocke J; Kopetschke K; Grießbach AS; Langhans V; Humrich JY; Biesen R; Dragun D; Radbruch A; Burmester GR; Riemekasten G; Enghard P
    Eur J Immunol; 2017 Jan; 47(1):180-192. PubMed ID: 27753073
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Utility of urinary transferrin and ceruloplasmin in patients with systemic lupus erythematosus for differentiating patients with lupus nephritis.
    Urrego T; Ortiz-Reyes B; Vanegas-García AL; Muñoz CH; González LA; Vásquez G; Gómez-Puerta JA
    Reumatol Clin (Engl Ed); 2020; 16(1):17-23. PubMed ID: 29530762
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urinary CD4 T cells identify SLE patients with proliferative lupus nephritis and can be used to monitor treatment response.
    Enghard P; Rieder C; Kopetschke K; Klocke JR; Undeutsch R; Biesen R; Dragun D; Gollasch M; Schneider U; Aupperle K; Humrich JY; Hiepe F; Backhaus M; Radbruch AH; Burmester GR; Riemekasten G
    Ann Rheum Dis; 2014 Jan; 73(1):277-83. PubMed ID: 23475982
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urine Galectin-3 binding protein reflects nephritis activity in systemic lupus erythematosus.
    Faustini F; Idborg H; Fuzzi E; Larsson A; Lie WR; Pötzsch S; Okitsu SL; Svenungsson E; Gunnarsson I
    Lupus; 2023 Feb; 32(2):252-262. PubMed ID: 36508734
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urinary vitamin D-binding protein, a novel biomarker for lupus nephritis, predicts the development of proteinuric flare.
    Go DJ; Lee JY; Kang MJ; Lee EY; Lee EB; Yi EC; Song YW
    Lupus; 2018 Sep; 27(10):1600-1615. PubMed ID: 29958502
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Levels of Proteinuria and Renal Pathology in Systemic Lupus Erythematosus Patients.
    Al Arfaj AS; Khalil N
    Saudi J Kidney Dis Transpl; 2023 Mar; 34(2):154-160. PubMed ID: 38146725
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urinary dedifferentiated podocytes as a non-invasive biomarker of lupus nephritis.
    Perez-Hernandez J; Olivares MD; Forner MJ; Chaves FJ; Cortes R; Redon J
    Nephrol Dial Transplant; 2016 May; 31(5):780-9. PubMed ID: 26932688
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of Urine sCD163 With Proliferative Lupus Nephritis, Fibrinoid Necrosis, Cellular Crescents and Intrarenal M2 Macrophages.
    Zhang T; Li H; Vanarsa K; Gidley G; Mok CC; Petri M; Saxena R; Mohan C
    Front Immunol; 2020; 11():671. PubMed ID: 32351512
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of urinary metabolites that distinguish membranous lupus nephritis from proliferative lupus nephritis and focal segmental glomerulosclerosis.
    Romick-Rosendale LE; Brunner HI; Bennett MR; Mina R; Nelson S; Petri M; Kiani A; Devarajan P; Kennedy MA
    Arthritis Res Ther; 2011; 13(6):R199. PubMed ID: 22152586
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Soluble TNF-R1, VEGF and other cytokines as markers of disease activity in systemic lupus erythematosus and lupus nephritis.
    Adhya Z; El Anbari M; Anwar S; Mortimer A; Marr N; Karim MY
    Lupus; 2019 May; 28(6):713-721. PubMed ID: 31046570
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urine levels of HMGB1 in Systemic Lupus Erythematosus patients with and without renal manifestations.
    Abdulahad DA; Westra J; Bijzet J; Dolff S; van Dijk MC; Limburg PC; Kallenberg CG; Bijl M
    Arthritis Res Ther; 2012 Aug; 14(4):R184. PubMed ID: 22892043
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Absence of Anti-Glomerular Basement Membrane Antibodies in 200 Patients With Systemic Lupus Erythematosus With or Without Lupus Nephritis: Results of the GOODLUPUS Study.
    Bourse Chalvon N; Orquevaux P; Giusti D; Gatouillat G; Tabary T; Tonye Libyh M; Chrusciel J; Drame M; Stockton-Bliard G; Amoura Z; Arnaud L; Lorenz HM; Blaison G; Bonnotte B; Magy-Bertrand N; Revuz S; Voll RE; Hinschberger O; Schwarting A; Pham BN; Martin T; Pennaforte JL; Servettaz A
    Front Immunol; 2020; 11():597863. PubMed ID: 33381119
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of urinary biomarker monocyte chemoattractant protein (MCP-1) in correlation with different histopathological classes of lupus nephritis in Egyptian patients.
    El-Shinnawy H; Mahmoud O; Abdelmohsen W; Ahmed A; Khedr L
    Egypt J Immunol; 2024 Jan; 31(1):116-123. PubMed ID: 38224276
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urinary ferritin creatinine ratio, a potential biomarker for lupus nephritis activity.
    Qi L; Xu J; Yang C; Hou X; Yang P
    Clin Rheumatol; 2021 Jan; 40(1):143-149. PubMed ID: 32557256
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Validity of immunoglobulin-binding protein 1 as a biomarker for lupus nephritis.
    Ebaid AM; Ezzeldin N; Abdelhady EI; Mohammed HA; Abdallah AL
    Lupus; 2023 Jan; 32(1):101-110. PubMed ID: 36418233
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urine ALCAM, PF4 and VCAM-1 Surpass Conventional Metrics in Identifying Nephritis Disease Activity in Childhood-Onset Systemic Lupus Erythematosus.
    Soliman SA; Haque A; Vanarsa K; Zhang T; Ismail F; Lee KH; Pedroza C; Greenbaum LA; Mason S; Hicks MJ; Wenderfer SE; Mohan C
    Front Immunol; 2022; 13():885307. PubMed ID: 35720325
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.